These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1884278)
1. Quantitation of canine plasma von Willebrand factor antigen using a commercial enzyme-linked immunosorbent assay. Johnstone IB; Crane S Can J Vet Res; 1991 Jan; 55(1):11-4. PubMed ID: 1884278 [TBL] [Abstract][Full Text] [Related]
2. An enzyme-linked immunosorbent assay (ELISA) for von Willebrand factor antigen (vWf-Ag) in canine plasma. Slappendel RJ; Frielink RA; Mol JA; Noordzij A; Hamer R Vet Immunol Immunopathol; 1992 Jun; 33(1-2):145-54. PubMed ID: 1632075 [TBL] [Abstract][Full Text] [Related]
3. A sensitive ELISA for von Willebrand factor (vWf:Ag). Ingerslev J Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116 [TBL] [Abstract][Full Text] [Related]
4. A sensitive immunoassay for von Willebrand factor. Benson RE; Catalfamo JL; Brooks M; Dodds WJ J Immunoassay; 1991; 12(3):371-90. PubMed ID: 1939665 [TBL] [Abstract][Full Text] [Related]
5. A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor. Benson RE; Catalfamo JL; Dodds WJ J Lab Clin Med; 1992 Apr; 119(4):420-7. PubMed ID: 1583394 [TBL] [Abstract][Full Text] [Related]
6. [The determination of von Willebrand factor activity in the plasma of dogs. 1. Experimental evaluation and methods]. Jurina K; Gropp F; Oechtering G Tierarztl Prax; 1996 Dec; 24(6):616-20. PubMed ID: 9139430 [TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997 [TBL] [Abstract][Full Text] [Related]
8. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis. Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195 [TBL] [Abstract][Full Text] [Related]
9. Application of an enzyme-linked immunosorbent assay (ELISA) to von Willebrand factor (vWF) and its derivatives. Silveira AM; Yamamoto T; Adamson L; Hessel B; Blombäck B Thromb Res; 1986 Jul; 43(1):91-102. PubMed ID: 2425450 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease. Favaloro EJ Thromb Haemost; 2010 Nov; 104(5):1009-21. PubMed ID: 20806123 [TBL] [Abstract][Full Text] [Related]
11. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs. Sabino EP; Erb HN; Catalfamo JL Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628 [TBL] [Abstract][Full Text] [Related]
12. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Direct comparison of commercial ELISA-based von Willebrand factor activity options. Favaloro EJ Am J Clin Pathol; 2000 Oct; 114(4):608-18. PubMed ID: 11026108 [TBL] [Abstract][Full Text] [Related]
13. A competitive ELISA technique for the measurement of von Willebrand factor antigen (vWF:Ag) using staphylococcal protein A peroxidase. Brien WF; Stewart MW Clin Biochem; 1986 Jun; 19(3):179-82. PubMed ID: 3488141 [TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor is present in the vascular endothelium from normal dogs and from Doberman pinscher dogs with a plasma von Willebrand factor deficiency. Meyers KM; Wardrop KJ; Helmick C; White F Thromb Res; 1990 Jan; 57(1):109-16. PubMed ID: 2405539 [TBL] [Abstract][Full Text] [Related]
15. Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers. Brooks M; Raymond S; Catalfamo J J Am Vet Med Assoc; 1996 Sep; 209(5):930-3. PubMed ID: 8790543 [TBL] [Abstract][Full Text] [Related]
16. Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA. Vanhoorelbeke K; Pareyn I; Schlammadinger A; Vauterin S; Hoylaerts MF; Arnout J; Deckmyn H Thromb Haemost; 2005 Jan; 93(1):165-71. PubMed ID: 15630508 [TBL] [Abstract][Full Text] [Related]
17. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239 [TBL] [Abstract][Full Text] [Related]
18. A comparative evaluation of a new automated assay for von Willebrand factor activity. Lawrie AS; Stufano F; Canciani MT; Mackie IJ; Machin SJ; Peyvandi F Haemophilia; 2013 Mar; 19(2):338-42. PubMed ID: 23205618 [TBL] [Abstract][Full Text] [Related]
19. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen. Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703 [TBL] [Abstract][Full Text] [Related]
20. [Application of collagen-binding assay for von Willebrand disease]. Zhou J; Jia YQ; Jiang H; Yang YM; Deng CQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]